SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Covanta Holding Corp – ‘10-K’ for 12/31/19 – ‘EX-4.8’

On:  Tuesday, 2/25/20, at 4:37pm ET   ·   For:  12/31/19   ·   Accession #:  225648-20-7   ·   File #:  1-06732

Previous ‘10-K’:  ‘10-K’ on 2/19/19 for 12/31/18   ·   Next & Latest:  ‘10-K’ on 2/19/21 for 12/31/20   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/25/20  Covanta Holding Corp              10-K       12/31/19  113:17M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.18M 
 2: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     33K 
 3: EX-21.1     Subsidiaries List                                   HTML     62K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     32K 
 5: EX-23.2     Consent of Experts or Counsel                       HTML     32K 
 9: EX-99.1     Miscellaneous Exhibit                               HTML    247K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     36K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     36K 
 8: EX-32       Certification -- §906 - SOA'02                      HTML     32K 
56: R1          Cover                                               HTML     93K 
97: R2          Consolidated Statements of Income                   HTML    113K 
84: R3          Consolidated Statements of Comprehensive Income     HTML     53K 
16: R4          Consolidated Statements of Comprehensive Income     HTML     32K 
                (Paranthetical)                                                  
53: R5          Consolidated Balance Sheets                         HTML    115K 
95: R6          Consolidated Balance Sheets (Parenthetical)         HTML     50K 
82: R7          Consolidated Statements of Cash Flows               HTML    173K 
20: R8          Consolidated Statements of Equity                   HTML     58K 
50: R9          Organization and Summary of Significant Accounting  HTML    211K 
                Policies (Notes)                                                 
103: R10         Recent Accounting Pronouncements (Notes)            HTML     38K  
87: R11         New Business and Asset Management (Notes)           HTML     50K 
30: R12         Dispositions and Discontinued Operations (Notes)    HTML     37K 
66: R13         Equity and Earnings Per Share ("Eps") (Notes)       HTML     45K 
102: R14         Revenues (Notes)                                    HTML     71K  
86: R15         Stock-Based Award Plans                             HTML    137K 
29: R16         Supplementary Information (Notes)                   HTML     96K 
65: R17         Income Taxes (Notes)                                HTML    151K 
101: R18         Accounts Receivable Securitization                  HTML     41K  
88: R19         Equity Method Investments (Notes)                   HTML     76K 
32: R20         Financial Instruments (Notes)                       HTML     77K 
43: R21         Derivative Instruments (Notes)                      HTML     42K 
107: R22         Intangible Assets and Goodwill                      HTML     95K  
68: R23         Consolidated Debt (Notes)                           HTML    224K 
31: R24         Leases (Notes)                                      HTML    139K 
42: R25         Commitments and Contingencies (Notes)               HTML     50K 
106: R26         Quarterly Data (Unaudited)                          HTML     81K  
67: R27         Subsequent Events                                   HTML     34K 
33: R28         Schedule Ii Valuation and Qualifying Accounts       HTML     71K 
41: R29         Organization and Summary of Significant Accounting  HTML    176K 
                Policies (Policies)                                              
62: R30         Organization and Summary of Significant Accounting  HTML    165K 
                Policies (Tables)                                                
26: R31         Equity and Earnings Per Share ("Eps") (Tables)      HTML     41K 
89: R32         Revenues (Tables)                                   HTML     37K 
104: R33         Stock-Based Award Plans (Tables)                    HTML    129K  
63: R34         Supplementary Information (Tables)                  HTML     98K 
27: R35         Income Taxes (Tables)                               HTML    149K 
90: R36         Accounts Receivable Securitization (Tables)         HTML     38K 
105: R37         Equity Method Investments (Tables)                  HTML     72K  
64: R38         Financial Instruments (Tables)                      HTML     69K 
25: R39         Derivative Instruments (Tables)                     HTML     34K 
47: R40         Intangible Assets and Goodwill (Tables)             HTML    100K 
39: R41         Consolidated Debt (Tables)                          HTML    171K 
69: R42         Leases (Tables)                                     HTML    100K 
108: R43         Commitments and Contingencies (Tables)              HTML     39K  
48: R44         Quarterly Data (Unaudited) (Tables)                 HTML     78K 
40: R45         Schedule Ii Valuation and Qualifying Accounts       HTML     71K 
                (Tables)                                                         
70: R46         Organization and Summary of Significant Accounting  HTML    328K 
                Policies - Additional Information (Details)                      
109: R47         New Business and Asset Management (Details)         HTML    143K  
49: R48         Dispositions and Other (Additional Information)     HTML     53K 
                (Details)                                                        
38: R49         Earnings Per Share Computations (Details)           HTML     41K 
23: R50         REVENUES - Revenue Recognition (Details)            HTML     38K 
61: R51         Revenues (Details)                                  HTML     36K 
92: R52         Stock Based Compensation (Additional Details)       HTML     55K 
                (Details)                                                        
77: R53         Share Based Compensation - Restricted Stock Awards  HTML     61K 
                (Details)                                                        
22: R54         Share Based Compensation - Restricted Stock Units   HTML     61K 
                (Details)                                                        
60: R55         STOCK-BASED AWARD PLANS - Performance Share         HTML     48K 
                Narratives (Details)                                             
91: R56         STOCK-BASED AWARD PLANS - Performance Shares        HTML     40K 
                Valuation Assumptions (Details)                                  
76: R57         STOCK-BASED AWARD PLANS - Performance Shares        HTML     50K 
                Rollforward (Details)                                            
24: R58         Stock Based Compensation - Stock Options (Details)  HTML     86K 
59: R59         Components of Other Operating Expenses (Details)    HTML     46K 
113: R60         Components of Impairment Charges (Details)          HTML     31K  
74: R61         Supplementary Balance Sheet Information (Details)   HTML     62K 
37: R62         SUPPLEMENTARY INFORMATION - Geographical            HTML     45K 
                Information (Details)                                            
46: R63         Income Taxes - Additional Information (Detail)      HTML    193K 
111: R64         Accounts Receivable Securitization (Details)        HTML     51K  
71: R65         Equity Method Investments (Details)                 HTML     42K 
34: R66         Equity Method Investments - Ownership Percentage    HTML     46K 
                in Equity Method Investments (Details)                           
44: R67         EQUITY METHOD INVESTMENTS - Summarized Financial    HTML     57K 
                Information (Details)                                            
110: R68         Fair Value Measurement of Assets and Liabilities    HTML     62K  
                (Detail)                                                         
75: R69         FINANCIAL INSTRUMENTS Financial Instruments         HTML     39K 
                Recorded at Carrying Amount (Details)                            
80: R70         Summary of Fair Value of Derivative Instruments     HTML     34K 
                Not Designated as Hedging Instruments in                         
                Consolidated Balance Sheets (Detail)                             
93: R71         Derivative Instruments - Additional Information     HTML     57K 
                (Detail)                                                         
52: R72         Intangible Assets (Details)                         HTML     75K 
15: R73         Schedule of Goodwill (Details)                      HTML     36K 
85: R74         Consolidated Debt Table (Details)                   HTML    133K 
98: R75         Credit Facilities (Details)                         HTML    114K 
58: R76         Senior Notes (Details)                              HTML     64K 
19: R77         Tax-Exempt Bonds (Details)                          HTML     79K 
78: R78         CONSOLIDATED DEBT Tax-Exempt Variable Rate Demand   HTML     32K 
                Bonds due 2043 (Details)                                         
99: R79         CONSOLIDATED DEBT Union Lease (Details)             HTML     35K 
81: R80         CONSOLIDATED DEBT Equipment Financing Arrangements  HTML     62K 
                (Details)                                                        
94: R81         Project Debt (Details)                              HTML     75K 
54: R82         CONSOLIDATED DEBT Deferred Financing Costs          HTML     34K 
                (Details)                                                        
17: R83         CONSOLIDATED DEBT Capitalized Interest (Details)    HTML     31K 
83: R84         CONSOLIDATED DEBT Dublin Project Financing          HTML     77K 
                (Details)                                                        
96: R85         LEASES - Lease Cost (Details)                       HTML     39K 
57: R86         LEASES - Balance Sheet Information (Details)        HTML     48K 
18: R87         LEASES - Supplemental Cash Flow Information         HTML     43K 
                (Details)                                                        
79: R88         LEASES - Lease Maturity Schedule (Details)          HTML     68K 
100: R89         LEASES - Narratives (Details)                       HTML     30K  
112: R90         Commitments and Contingencies (Details)             HTML     48K  
72: R91         Quarterly Data (Unaudited) (Details)                HTML     57K 
36: R92         SUBSEQUENT EVENTS Subsequent Events (Details)       HTML     56K 
45: R93         Schedule II Valuation and Qualifying Accounts       HTML     44K 
                (Details)                                                        
51: R9999       Uncategorized Items - cva-123119x10k.htm            HTML     39K 
28: XML         IDEA XML File -- Filing Summary                      XML    201K 
55: XML         XBRL Instance -- cva-123119x10k_htm                  XML   3.78M 
21: EXCEL       IDEA Workbook of Financial Reports                  XLSX    140K 
11: EX-101.CAL  XBRL Calculations -- cva-20191231_cal                XML    283K 
12: EX-101.DEF  XBRL Definitions -- cva-20191231_def                 XML   1.54M 
13: EX-101.LAB  XBRL Labels -- cva-20191231_lab                      XML   2.80M 
14: EX-101.PRE  XBRL Presentations -- cva-20191231_pre               XML   1.86M 
10: EX-101.SCH  XBRL Schema -- cva-20191231                          XSD    295K 
73: JSON        XBRL Instance as JSON Data -- MetaLinks              558±   852K 
35: ZIP         XBRL Zipped Folder -- 0000225648-20-000007-xbrl      Zip    628K 


‘EX-4.8’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  
Exhibit 4.8

DESCRIPTION OF COMMON STOCK REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES AND DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

DESCRIPTION OF COMMON STOCK

The following description of the Common Stock of Covanta Holding Corporation, a Delaware corporation (the “Company”) is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to the Company’s Restated Certificate of Incorporation (the “Certificate”) and Amended and Restated Bylaws (the Bylaws,” and together with the Certificate, the “Charter Documents”), each of which are incorporated by reference as an exhibit to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission. For additional information, please read the Company’s Charter Documents and the applicable provisions of the Delaware General Corporation Law (the “DGCL”).\

Authorized Capital Shares

The Company is authorized to issue two classes of shares designated “Preferred Stock” and “Common Stock”, respectively. The total number of shares of capital stock the Corporation is authorized to issue is 260,000,000. The number of shares of Preferred Stock authorized to be issued is 10,000,000 and the number of shares of Common Stock authorized to be issued is 250,000,000. The par value of each share in each class is $.10. There is no Preferred Stock currently issued and outstanding.

Voting Rights

Each holder of an outstanding share of the Company’s Common Stock is entitled to cast one vote for each share registered on all matters to be voted upon by the stockholders. There shall be no cumulative voting of shares. Unless otherwise required by law or the Charter Documents, the election of directors in an uncontested election shall be decided by a majority of the votes cast at a meeting of the stockholders by the holders of stock entitled to vote in the election. A majority of the votes cast means that the number of shares voted “for” a nominee must exceed the votes cast “against” such nominee’s election (with abstentions and broker non-votes not counting as votes cast either for or against a nominee’s election and votes “withheld” being counted as votes “against”). In a contested election for directors, the election for directors shall be decided by plurality vote. Unless otherwise required by law or the Charter Documents, all other questions brought before any meeting of stockholders shall be decided by the vote of the holders of a majority of the total number of votes of the stock present in person or represented by proxy at the meeting and entitled to vote on such question, voting as a single class.

Power to Amend the Bylaws

The board of directors of the Company (the “Board”) or the stockholders of the Company may alter, amend or repeal the Bylaws, provided, however, that any amendment to the Bylaws by the stockholders shall require, in addition to any greater or additional vote required by Delaware law or the Certificate, the affirmative vote of the holders of a majority in voting power of the outstanding stock entitled to vote thereon.

Dividend Rights

The Board may, out of funds legally available therefor, at any regular or special meeting, declare dividends upon the then outstanding shares of Common Stock, subject to the rights, if any, of any preferred stockholders.

Liquidation Rights

Upon liquidation, dissolution or winding up, all holders of our common stock are entitled to share ratably in any assets available for distribution, after payment of any preferential amounts due to the holders of any series of our preferred stock.

Preemptive, Redemption or Conversion Rights

The Common Stock is not redeemable, is not subject to sinking fund provisions, does not have any conversion rights and is not subject to call. Holders of shares of Common Stock have no preemptive rights to maintain their percentage of ownership in future offerings or sales of stock of the Company.

Listing

Our Common Stock is traded on New York Stock Exchange under the trading symbol “CVA.”



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/25/204
For Period end:12/31/19DEF 14A
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/19/21  Covanta Holding Corp.             10-K       12/31/20  111:15M
 8/12/20  Covanta Holding Corp.             424B2                  1:1.5M                                   Broadridge Fin’l So… Inc
 8/11/20  Covanta Holding Corp.             424B5                  1:1.5M                                   Broadridge Fin’l So… Inc
Top
Filing Submission 0000225648-20-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 1:11:16.1pm ET